Colleen Hadigan
Chief Medical Officer and Clinical Director · Clinical Center at the National Institutes of Health
Credentials: · · · ·
History
Research
The Journal of Clinical Endocrinology & Metabolism · 2007 · 1,331 citations
Clinical Infectious Diseases · 2001 · First of 12 authors · 543 citations
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
Journal of Clinical Investigation · 2018 · 420 citations
42 papers
18 papers
- AG
15 papers
- TS
15 papers · 2 as a fellow
- MT
11 papers
- JM
9 papers
9 papers
- BW
8 papers
Grants
- 2014–2019
Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative U01 Grant
National Institute of Allergy and Infectious Diseases · U01
PI · $2M · Massachusetts General Hospital
- 2003–2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $509.6K · Massachusetts General Hospital
- 2000–2005
Insulin Resistance in the Hiv Lipodystrophy Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases · K23
Contact PI · $648.4K · Massachusetts General Hospital
- 2002–2005
Anti-Lipolytic Therapy for HIV Lipodystrophy
National Heart, Lung, and Blood Institute · R21
Contact PI · $484.7K · Massachusetts General Hospital
Clinical trials
- 2019–2022
Principal investigator · Completed · Phase 1
National Institutes of Health Clinical Center (CC)
- 2018–2021
2-5 Intermittent Caloric Restriction in HIV
Principal investigator · Terminated
National Institute of Allergy and Infectious Diseases (NIAID)
- 2015–2017
Cardiometabolic Effects of Eplerenone in HIV Infection
Principal investigator · Terminated · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
- 2013–2017
The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers
Principal investigator · Completed · Phase 1
National Institutes of Health Clinical Center (CC)